Citations 1
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and SARS-CoV-2–Related Hospitalizations: A Statewide Report From the Minnesota Electronic Health Record Consortium
Drawz, Paul E. , DeSilva, Malini B. , Bodurtha, Peter , Vazquez‐Benitez, Gabriela , Murray, Anne M. , Dudley, R. Adams , Waring, Stephen C. , Murphy, Daniel , Muscoplat, Miriam Halstead, Meléndez, Victor, McFarling, Lynn, Lupu, Roxana , Johnson, Steve , Johnson, Steven G. , Waring, Stephen C. , Drawz, Paul , Chamberlain, Alanna M. , Kharbanda, Anupam B. , Murphy, Daniel, Melendez, Victor, Margolis, Karen L. , Winkelman, Tyler N A
Clinical Infectious Diseases | February 3, 2022 | Volume: 75 | Issue: 5 | Pages: 890-892
Abstract Using vaccine data combined with electronic health records, we report that mRNA boosters provide greater protection than a 2-dose regimen against SARS-CoV-2 infection and related hospitalizations. The benefit of a booster was more evident in the elderly and those with comorbidities.